| 1. |
Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res, 2014, 74(11): 2913-2921.
|
| 2. |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132.
|
| 3. |
Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin, 2017, 67(1): 7-30.
|
| 4. |
Mirkin KA, Hollenbeak CS, Wong J. Greater lymph node retrieval and lymph node ratio impacts survival in resected pancreatic cancer. J Surg Res, 2017, 220: 12-24.
|
| 5. |
Morales-Oyarvide V, Rubinson DA, Dunne RF, et al. Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival. Br J Cancer, 2017, 117(12): 1874-1882.
|
| 6. |
Liu C, Chen R, Chen Y, et al. Should a standard lymphadenectomy during pancreatoduodenectomy exclude para-aortic lymph nodes for all cases of resectable pancreatic head cancer? A consensus statement by the Chinese Study Group for Pancreatic Cancer (CSPAC). Int J Oncol, 2015, 47(4): 1512-1516.
|
| 7. |
Agalianos C, Gouvas N, Papaparaskeva K, et al. Positive para-aortic lymph nodes following pancreatectomy for pancreatic cancer. Systematic review and meta-analysis of impact on short term survival and association with clinicopathologic features. HPB (Oxford), 2016, 18(8): 633-641.
|
| 8. |
Kang MJ, Jang JY, Kim SW. Surgical resection of pancreatic head cancer: what is the optimal extent of surgery? Cancer Lett, 2016, 382(2): 259-265.
|
| 9. |
Matsuno S, Egawa S, Fukuyama S, et al. Pancreatic cancer registry in Japan: 20 years of experience. Pancreas, 2004, 28(3): 219-230.
|
| 10. |
Kawarada Y. New classification of pancreatic carcinoma－Japan Pancreas Society. Nihon Shokakibyo Gakkai Zasshi, 2003, 100(8): 974-980.
|
| 11. |
Pedrazzoli S, Beger HG, Obertop H, et al. A surgical and pathological based classification of resective treatment of pancreatic cancer. Summary of an international workshop on surgical procedures in pancreatic cancer. Dig Surg, 1999, 16(4): 337-345.
|
| 12. |
Tol JA, Gouma DJ, Bassi C, et al. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS). Surgery, 2014, 156(3): 591-600.
|
| 13. |
Orci LA, Meyer J, Combescure C, et al. A meta-analysis of extended versus standard lymphadenectomy in patients undergoing pancreatoduodenectomy for pancreatic adenocarcinoma. HPB (Oxford), 2015, 17(7): 565-572.
|
| 14. |
Ke K, Chen W, Chen Y. Standard and extended lymphadenectomy for adenocarcinoma of the pancreatic head: a meta-analysis and systematic review. J Gastroenterol Hepatol, 2014, 29(3): 453-462.
|
| 15. |
Aimoto T, Mizutani S, Kawano Y, et al. Left posterior approach pancreaticoduodenectomy with total mesopancreas excision and circumferential lymphadenectomy around the superior mesenteric artery for pancreatic head carcinoma. J Nippon Med Sch, 2013, 80(6): 438-445.
|
| 16. |
Slidell MB, Chang DC, Cameron JL, et al. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis. Ann Surg Oncol, 2008, 15(1): 165-174.
|
| 17. |
Fortner JG. Regional resection of cancer of the pancreas: a new surgical approach. Surgery, 1973, 73(2): 307-320.
|
| 18. |
Ishikawa O, Ohhigashi H, Sasaki Y, et al. Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head. Ann Surg, 1988, 208(2): 215-220.
|
| 19. |
Manabe T, Ohshio G, Baba N, et al. Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas. Cancer, 1989, 64(5): 1132-1137.
|
| 20. |
Pedrazzoli S, DiCarlo V, Dionigi R, et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg, 1998, 228(4): 508-517.
|
| 21. |
Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg, 2002, 236(3): 355-368.
|
| 22. |
Farnell MB, Pearson RK, Sarr MG, et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery, 2005, 138(4): 618-628, 628-630.
|
| 23. |
Nimura Y, Nagino M, Takao S, et al. Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas: long-term results of a Japanese multicenter randomized controlled trial. J Hepatobiliary Pancreat Sci, 2012, 19(3): 230-241.
|
| 24. |
Jang JY, Kang MJ, Heo JS, et al. A prospective randomized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer. Ann Surg, 2014, 259(4): 656-664.
|
| 25. |
Tempero MA, Malafa MP, Al-Hawary M, et al. Pancreatic adenocarcinoma, version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 2017, 15(8): 1028-1061.
|
| 26. |
Ducreux M, Cuhna AS, Caramella C, et al. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2015, 26 Suppl 5: v56-v68.
|
| 27. |
Shinkai T, Kato H, Hayasaki A, et al. I. The efficacy of preoperative adjuvant treatment for pancreatic ductal adenocarcinoma based on the resectability criteria according to JPS 7th. Gan To Kagaku Ryoho, 2017, 44(10): 837-844.
|
| 28. |
楊尹默, 劉子文, 趙玉沛. 胰腺癌診治指南(2014). 中華外科雜志, 2014, 52(12): 1-7.
|
| 29. |
Jang JY, Kang JS, Han Y, et al. Long-term outcomes and recurrence patterns of standard versus extended pancreatectomy for pancreatic head cancer: a multicenter prospective randomized controlled study. J Hepatobiliary Pancreat Sci, 2017, 24(7): 426-433.
|
| 30. |
Paiella S, Butturini G, Bassi C. Different ideas of nodal grouping in standard and extended lymphadenectomy during pancreaticoduodenectomy for pancreatic head cancer. Ann Surg, 2017, 265(6): E73-E74.
|
| 31. |
金鋼, 王槐志, 陳汝福. 胰腺癌切除與淋巴結清掃范圍. 中國實用外科雜志, 2017, 37(7): 764-765.
|
| 32. |
Patel BN, Olcott E, Jeffrey RB. Extrapancreatic perineural invasion in pancreatic adenocarcinoma. Abdom Radiol (NY), 2018, 43(2): 323-331.
|
| 33. |
Takahashi H, Ohigashi H, Ishikawa O, et al. Perineural invasion and lymph node involvement as indicators of surgical outcome and pattern of recurrence in the setting of preoperative gemcitabine-based chemoradiation therapy for resectable pancreatic cancer. Ann Surg, 2012, 255(1): 95-102.
|
| 34. |
Chatterjee D, Katz MH, Rashid A, et al. Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. Am J Surg Pathol, 2012, 36(3): 409-417.
|
| 35. |
Wang PH, Song N, Shi LB, et al. The relationship between multiple clinicopathological features and nerve invasion in pancreatic cancer. Hepatobiliary Pancreat Dis Int, 2013, 12(5): 546-551.
|
| 36. |
Bapat AA, Hostetter G, Von Hoff DD, et al. Perineural invasion and associated pain in pancreatic cancer. Nat Rev Cancer, 2011, 11(10): 695-707.
|
| 37. |
Schlitter AM, Esposito I. Definition of microscopic tumor clearance (R0) in pancreatic cancer resections. Cancers (Basel), 2010, 2(4): 2001-2010.
|
1/5
WeChat